Skip to content
HowShorted

Delek US Holdings, Inc. short interest in 2025

In 2025, Delek US Holdings, Inc.'s disclosed short interest ran from 15.57% of shares outstanding on 15 Jan 2025 to 18.37% on 31 Dec 2025, a change of +2.80 percentage points. The year's high was 18.37% on 31 Dec 2025 and its low 11.71% on 15 Aug 2025, averaging 14.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.94 days on 31 Jan 2025. Full history: Delek US Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Delek US Holdings, Inc. in 2025

2025 in figures

Start of year
15.57% (15 Jan 2025)
End of year
18.37% (31 Dec 2025)
Change
+2.80 pp
High
18.37% (31 Dec 2025)
Low
11.71% (15 Aug 2025)
Average
14.97%
Highest days to cover
9.94 (31 Jan 2025)
SEC filings marked
8

Every report in 2025

Delek US Holdings, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202515.57%8.37
31 Jan 202515.04%9.94
14 Feb 202513.65%7.20
28 Feb 202513.97%4.32results (8-K), 10-K filed
14 Mar 202514.88%4.43
31 Mar 202514.41%6.84
15 Apr 202516.42%5.78
30 Apr 202515.74%7.70
15 May 202515.89%5.0510-Q filed, results (8-K)
30 May 202514.09%4.95
13 Jun 202513.96%5.66
30 Jun 202512.71%4.08
15 Jul 202512.32%3.95
31 Jul 202511.74%4.35
15 Aug 202511.71%4.0210-Q filed, results (8-K)
29 Aug 202511.72%2.38
15 Sep 202514.39%3.54
30 Sep 202516.43%4.83
15 Oct 202517.40%7.37
31 Oct 202515.83%7.78
14 Nov 202518.09%5.3910-Q filed, results (8-K)
28 Nov 202516.90%8.15
15 Dec 202518.08%8.67
31 Dec 202518.37%9.15

See also: Delek US Holdings, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.